San Diego-based Molecular Assemblies said this morning that it has raised $24M in a Series A funding round, which came from Agilent Technologies, iSelect Fund, Codexis, Alexandria Venture Investments, and Argonautic Ventures, as well as LYFE Capital. According to the company, it will use the funding to advance the company's proprietary enzymatic DNA synthesis technology toward early commercialization efforts. Molecular Assemblies is led by President and CEO, Michael J. Kamdar.
Tags
dna
molecular
picks
synthesis
Category:
Financial Services
Latest from this category |
|